A Small-Molecule Inhibitor of Bax and Bak Oligomerization Prevents Genotoxic Cell Death and Promotes Neuroprotection
Xin Niu1, Hetal Brahmbhatt2, Philipp Mergenthaler3
1Department of Biochemistry and Biomedical Sciences, McMaster University, Hamilton, ON L8S 4L8, Canada; Department of Biochemistry and Molecular Cell Biology, Institutes of Medical Sciences, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China.
Abstract:
Aberrant apoptosis can lead to acute or chronic degenerative diseases. Mitochondrial outer membrane permeabilization (MOMP) triggered by the oligomerization of the Bcl-2 family proteins Bax/Bak is an irreversible step leading to execution of apoptosis. Here, we describe the discovery of small-molecule inhibitors of Bax/Bak oligomerization that prevent MOMP. We demonstrate that these molecules disrupt multiple, but not all, interactions between Bax dimer interfaces thereby interfering with the formation of higher-order oligomers in the MOM, but not recruitment of Bax to the MOM. Small-molecule inhibition of Bax/Bak oligomerization allowed cells to evade apoptotic stimuli and rescued neurons from death after excitotoxicity, demonstrating that oligomerization of Bax is essential for MOMP. Our discovery of small-molecule Bax/Bak inhibitors provides novel tools for the investigation of the mechanisms leading to MOMP and will ultimately facilitate development of compounds inhibiting Bax/Bak in acute and chronic degenerative diseases.
Insights
Scientists discovered small molecules that inhibit Bax/Bak protein oligomerization, a key step in apoptosis. These inhibitors prevent mitochondrial outer membrane permeabilization (MOMP) and protect cells, offering potential treatments for degenerative diseases.
Area of Science:
- Cell Biology
- Biochemistry
- Pharmacology
Background:
- Aberrant apoptosis contributes to acute and chronic degenerative diseases.
- Mitochondrial outer membrane permeabilization (MOMP) is an irreversible apoptosis execution step, triggered by Bax/Bak protein oligomerization.
- Targeting Bax/Bak oligomerization presents a therapeutic strategy for controlling apoptosis.
Purpose of the Study:
- To discover and characterize small-molecule inhibitors of Bax/Bak oligomerization.
- To investigate the mechanism by which these inhibitors prevent MOMP.
- To evaluate the therapeutic potential of inhibiting Bax/Bak oligomerization in cellular models of neurodegeneration.
Main Methods:
- High-throughput screening for small-molecule inhibitors of Bax/Bak oligomerization.
- Biochemical assays to assess disruption of Bax dimer interfaces and higher-order oligomer formation.
- Cell-based assays to evaluate protection against apoptotic stimuli and excitotoxicity in neuronal models.
Main Results:
- Discovery of novel small molecules that inhibit Bax/Bak oligomerization.
- Demonstrated that inhibitors interfere with Bax dimer interactions, preventing higher-order oligomer formation at the MOM.
- Inhibitors prevented MOMP, allowed cells to evade apoptosis, and rescued neurons from excitotoxicity-induced death.
Conclusions:
- Bax/Bak oligomerization is essential for MOMP.
- Small-molecule Bax/Bak inhibitors are effective tools for studying MOMP mechanisms.
- These inhibitors hold promise for developing new treatments for acute and chronic degenerative diseases by modulating apoptosis.
Related Concept Videos
Negative Regulator Molecules
The Blood-brain Barrier
Drugs that Stabilize Microtubules
The Intrinsic Apoptotic Pathway
Drugs that Destabilize Microtubules
Cellular Injury V: Apoptosis and Autophagy


